Back to Search Start Over

Central giant cell granulomas of the jaws stromal cells harbour mutations and have osteogenic differentiation capacity, in vivo and in vitro.

Authors :
Miguita, Lucyene
de Souza, Juliana Cristina
Bastos, Victor Coutinho
Pereira, Nubia Braga
de Freitas, Raphaela Alvarenga Braga
Guimarães, Leticia Martins
de Avelar, Gleide Fernandes
Andrade, Luciana Oliveira
Dutra, Walderez Ornelas
Nunes, Fábio Daumas
Castro, Wagner Henriques
de Lacerda, Julio Cesar Tanos
Reis, Amanda Maria Sena
Bernardes, Vanessa Fátima
Diniz, Marina Gonçalves
Gomez, Ricardo Santiago
Gomes, Carolina Cavalieri
Source :
Journal of Oral Pathology & Medicine. Feb2022, Vol. 51 Issue 2, p206-216. 11p. 1 Color Photograph, 1 Chart, 4 Graphs.
Publication Year :
2022

Abstract

Background: Central giant cell granulomas (CGCG) of the jaws are osteolytic lesions that may behave aggressively and respond poorly to surgery. Microscopically, in addition to giant cells, there is a mononuclear cell population composed of macrophage/monocytic cells and spindle‐shaped cells of mesenchymal origin. Seventy two percent of these tumours harbour mutually exclusive TRPV4, KRAS and FGFR1 mutations. We aimed to assess the mutational status of mononuclear and giant cells and the osteogenic potential of stromal cells in vitro and in vivo. Methods and Results: We screened CGCG for signature mutations and used laser‐capture microdissection to demonstrate that the mutations are restricted to the mononuclear cells. Additionally, we established CGCG primary cell culture and observed that the cells retained the mutations throughout passages. By flow cytometry, we observed predominance of CD14−CD51−CD61− cells, consistent with the expected profile for stromal cells. Considering the mesenchymal origin of stromal cells, we assessed the osteogenic differentiation potential of CGCG cells in culture by cytochemistry (von Kossa and alizarin red staining), alkaline phosphatase (ALP) activity assay and gene expression of osteogenic markers. CGCG cells presented self‐capacity to increase ALP levels in a time‐dependent manner and under osteogenic induction presented increasing number of calcium deposits, and overall higher expression of osteocalcin, RUNX2, ALPL and osteopontin than cells without osteogenic induction. A patient‐derived xenograft model for CGCG was established, and osteoid material deposition was observed. Conclusion: Collectively, the results confirm that the signature mutations are restricted to stromal cells in CGCG, and the in vitro and in vivo results support that these cells have the capacity to differentiate into osteoblasts, in line with the bone formation often observed in the stroma of these lesions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09042512
Volume :
51
Issue :
2
Database :
Academic Search Index
Journal :
Journal of Oral Pathology & Medicine
Publication Type :
Academic Journal
Accession number :
155282850
Full Text :
https://doi.org/10.1111/jop.13274